Lexaria Expands R&D Program to Address US$28 Billion Hypertension Market with Addition of Two Human Clinical Studies

Go back to Lexaria Expands R&D Program to Address US$28 Billion Hypertension Market with Addition of Two Human Clinical Studies
(NASDAQ: LEXX) Delayed: 6.19 -0.31 (4.77%)
Previous Close $6.50    52 Week High
Open $6.46    52 Week Low
Day High $6.50    P/E N/A 
Day Low $6.01    EPS
Volume 118,036       

(NASDAQ: LEXXW) Delayed: 2.89 -0.08 (2.69%)
Previous Close $2.97    52 Week High
Open $2.72    52 Week Low
Day High $2.89    P/E N/A 
Day Low $2.66    EPS
Volume 4,802